The treatment of congenital lactic acidoses

Journal of Inherited Metabolic Disease

Volumn 19, Issue 4, 1996, Pages 573-580

  Morris, A A M ^a   Leonard, J V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROACETIC ACID; RIBOFLAVIN; SCAVENGER; THIAMINE;

CELL METABOLISM; CONFERENCE PAPER; DIET THERAPY; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; LACTIC ACIDOSIS; PATHOPHYSIOLOGY; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; RESPIRATORY CHAIN;

EID: 0029773867     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01799117     Document Type: Conference Paper

References (44)

1. Abe K, Fujimura H, Nishikawa Y, et al (1991) Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neurol Scand 83: 356-359.
2. 31P NMR. Magn Reson Med 1: 307-315.
3. Arnold DL, Taylor DJ, Radda GK (1985) Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 18: 189-196.
4. Arts WF, Scholte HR, Bogaard JM, Kerrebijn KG, Luyt-Houwen IE (1983) NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin. Lancet 2: 581-582.
5. Bakker HD, Scholte HR, Jeneson JA, Busch HF, Abeling NG, van Gennip AH (1994) Vitaminresponsive complex I deficiency in a myopathie patient with increased activity of the terminal respiratory chain and lactic acidosis. J Inher Metab Dis 17: 196-204.
6. Beal MF (1992) Does impairment of energy metabolism lead to excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31: 119-130.
7. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42: 1203-1208.
8. Bernsen PL, Gabreels FJ, Ruitenbeek W, Hamburger HL (1993) Treatment of complex I deficiency with riboflavin. J Neurol Sci 118: 181-187.
9. Bonne G, Benelli C, De-Meirleir L, et al (1993) El pyruvate dehydrogenase deficiency in a child with motor neuropathy. Pediatr Res 33: 284-288.
10. Bourgeron T, Rustin P, Chretien D, et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genetics 11: 144-149.
11. Bresolin N, Doriguzzi C, Ponzetto C, et al (1990) Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 100: 70-78.
12. Brown GK (1994) Metabolic disorders of embryogenesis. J Inher Metab Dis 17: 448-458.
13. Burlina AB, Milanesi O, Biban P, et al (1993) Beneficial effect of sodium dichloroacetate in muscle cytochrome c oxidase deficiency. Eur J Pediatr 152: 537.
14. Chance B, Sies H, Boveris A (1979) Hydrogen peroxide metabolism in mammalian organs. Phys Rev 59: 527-605.
15. Chrzanowska-Lightowlers ZMA, Lightowlers RN, Turnbull DM (1995) Gene therapy for mitochondrial disorders: is it possible? Gene Ther 2: 311-316.
16. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL (1995) Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45: 1193-1198.
17. DiMauro S, Nicholson JF, Hays P (1983) Benign infantile mitochondrial myopathy due to a reversible cytochrome c oxidase deficiency. Ann Neurol 14: 226-234.
18. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 81: 3529-3533.
19. Falk RE, Cederbaum SD, Blass JP, Gibson GE, Pieter Kark RA, Carrel RE (1976) Ketogenic diet in the management of pyruvate dehydrogenase deficiency. Pediatrics 58: 713-721.
20. Fujii T, Van Coster RN, Old SE, et al (1994) Pyruvate dehydrogenase deficiency: molecular basis for intrafamilial heterogeneity. Ann Neurol 36: 83-89.
21. Griebel V, Krageloh-Mann I, Ruitenbeek W, Trijbels JM, Paulus W (1990) A mitochondrial myopathy in an infant with lactic acidosis. Dev Med Child Neurol 32: 528-531.
22. 10 and idebenone. J Neurol Sci 90: 263-271.
23. Krageloh-Mann I, Grodd W, Niemann G, Haas G, Ruitenbeek W (1992) Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy. Pediatr Neurol 8: 60-64.
24. Matalon R, Stumpf DA, Michals K, Hart RD, Parks JK, Goodman SI (1984) Lipoamide dehydrogenase deficiency with primary lactic acidosis: favourable response to treatment with oral lipoic acid. J Pediatr 104: 65-69.
25. 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 43: 884-890.
26. Morris A, Bindoff LA, Jackson MJ, et al (1995) Neonatal Fanconi syndrome and lactic acidosis due to deficiency of complex III of the mitochondrial respiratory chain. Pediatr Nephrol 9: 547-551.
27. Naito E, Ito M, Takeda E, Yokota I, Yoshijima S, Kuroda Y (1994) Molecular analysis of abnormal pyruvate dehydrogenase in a patient with thiamine-responsive congenital lactic acidemia. Pediatr Res 36: 340-346.
28. Narisawa K, Endo H, Miyabayashi S, Tada K (1992) Thiamine responsive pyruvate dehydrogenase deficiency. J Nutr Sci Vitaminol Tokyo 585-588.
29. 31P NMR study. Neurology 39: 399-493.
30. Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86: 2379-2382.
31. Ostman-Smith I, Brown G, Johnson A, Land J (1994) Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid. Br Heart J 72: 349-353.
32. 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 42: 2147-2152.
33. Piccolo G, Banfi P, Azan G, et al (1991) Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia. J Neurol Sci 105: 57-60.
34. 31P NMR examination of two patients with NADHCoQ reductase deficiency. Nature 295: 608-609.
35. 1 component of the complex. J Pediatr 111: 525-533.
36. Roodhooft AM, Van Acker KJ, Martin JJ, Ceuterick C, Scholte HR, Luyt-Houwen IE (1986) Benign mitochondrial myopathy with deficiency of NADH-CoQ reductase and cytochrome c oxidase. Neuropediatrics 17: 221-226.
37. Saijo T, Naito E, Ito M, Takeda E, Hashimoto T, Kuroda Y (1991) Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics 22: 166-167.
38. Scholte HR, Busch HF, Luyt-Houwen IE (1992) Vitamin-responsive pyruvate dehydrogenase deficiency in a young girl with external ophthalmoplegia, myopathy and lactic acidosis. J Inher Metab Dis 15: 331-334.
39. Stacpoole PW, Wright EC, Baumgartner, et al (1992) A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med 327: 1564-1569.
40. Toth PP, el-Shanti H, Eivins S, Rhead WJ, Klein JM (1993) Transient improvement of congenital lactic acidosis in a male infant with pyruvate decarboxylase deficiency treated with dichloroacetate. J Pediatr 123: 427-430.
41. Tulinius MH, Eriksson BO, Hjalmarson O, Holme E, Oldfors A (1989) Mitochondrial myopathy and cardiomyopathy in siblings. Pediatr Neurol 5: 182-188.
42. Van Erven PMM, Cillessen JPM, Eekhoof BMW, et al (1987) Leigh syndrome, a mitochondrial encephalo(myo)pathy. Clin Neurol Neurosurg 89: 217-230.
43. Wijburg FA, Barth PG, Bindoff LA, et al (1992) Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics 23: 147-152.
44. Zierz S, Jahns G, Jerusalem F (1989) Coenzyme Q in serum and muscle of 5 patients with Keams-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol 236: 97-101.